Domenico Tricò1,2, Alfonso Galderisi3, Andrea Mari4, David Polidori5, Brittany Galuppo6, Bridget Pierpont6, Stephanie Samuels6, Nicola Santoro6,7, Sonia Caprio6. 1. Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy. 2. Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy. 3. Department of Woman and Child's Health, University of Padova, Padova, Italy. 4. Institute of Neuroscience, National Research Council, Padova, Italy. 5. Janssen Research & Development, San Diego, California, USA. 6. Department of Pediatrics, Pediatrics Endocrinology and Diabetes Section, Yale School of Medicine, New Haven, Connecticut, USA. 7. Department of Medicine and Health Sciences, "V.Tiberio" University of Molise Via de Sanctis, Campobasso, Italy.
Abstract
AIM: To evaluate whether intrahepatic fat accumulation contributes to impaired insulin clearance and hepatic insulin resistance across different ethnic groups. METHODS: The intrahepatic fat content (HFF%) was quantified by magnetic resonance imaging in a multi-ethnic cohort of 632 obese youths aged 7-18 years at baseline and after a 2-year follow-up. Insulin secretion rate (ISR), endogenous insulin clearance (EIC) and hepatic insulin resistance index (HIRI) were estimated by modelling glucose, insulin and C-peptide data during 3-hour, 9-point oral glucose tolerance tests. RESULTS: African American youths exhibited the lowest HFF% and a prevalence of non-alcoholic fatty liver disease (NAFLD) less than half of that shown by Caucasians and Hispanics. Furthermore, African Americans had lower EIC and glucose-stimulated ISR, despite similar HIRI and plasma insulin levels, compared with Caucasians and Hispanics. EIC and HIRI were markedly reduced in individuals with NAFLD and declined across group-specific HFF% tertiles in all ethnic groups. Consistently, the HFF% correlated with EIC and HIRI, irrespective of the ethnic background, after adjustment for age, sex, ethnicity, adiposity, waist-hip ratio, pubertal status and plasma glucose levels. An increased HFF% at follow-up was associated with decreased EIC and increased HIRI across all groups. CONCLUSIONS: Intrahepatic lipid accumulation is associated with reduced insulin clearance and hepatic insulin sensitivity in obese youths, irrespective of their ethnic background.
AIM: To evaluate whether intrahepatic fat accumulation contributes to impaired insulin clearance and hepatic insulin resistance across different ethnic groups. METHODS: The intrahepatic fat content (HFF%) was quantified by magnetic resonance imaging in a multi-ethnic cohort of 632 obese youths aged 7-18 years at baseline and after a 2-year follow-up. Insulin secretion rate (ISR), endogenous insulin clearance (EIC) and hepatic insulin resistance index (HIRI) were estimated by modelling glucose, insulin and C-peptide data during 3-hour, 9-point oral glucose tolerance tests. RESULTS: African American youths exhibited the lowest HFF% and a prevalence of non-alcoholic fatty liver disease (NAFLD) less than half of that shown by Caucasians and Hispanics. Furthermore, African Americans had lower EIC and glucose-stimulated ISR, despite similar HIRI and plasma insulin levels, compared with Caucasians and Hispanics. EIC and HIRI were markedly reduced in individuals with NAFLD and declined across group-specific HFF% tertiles in all ethnic groups. Consistently, the HFF% correlated with EIC and HIRI, irrespective of the ethnic background, after adjustment for age, sex, ethnicity, adiposity, waist-hip ratio, pubertal status and plasma glucose levels. An increased HFF% at follow-up was associated with decreased EIC and increased HIRI across all groups. CONCLUSIONS: Intrahepatic lipid accumulation is associated with reduced insulin clearance and hepatic insulin sensitivity in obese youths, irrespective of their ethnic background.
Authors: Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs Journal: Hepatology Date: 2004-12 Impact factor: 17.425
Authors: Catherine W Yeckel; Ram Weiss; James Dziura; Sara E Taksali; Sylvie Dufour; Tania S Burgert; William V Tamborlane; Sonia Caprio Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: Sheela Deivanayagam; B Selma Mohammed; Bernadette E Vitola; Gihan H Naguib; Tamir H Keshen; Erik P Kirk; Samuel Klein Journal: Am J Clin Nutr Date: 2008-08 Impact factor: 7.045
Authors: Maria A Marini; Simona Frontoni; Elena Succurro; Franco Arturi; Teresa V Fiorentino; Angela Sciacqua; Francesco Perticone; Giorgio Sesti Journal: Acta Diabetol Date: 2013-08-30 Impact factor: 4.280
Authors: Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo Journal: Int J Mol Sci Date: 2021-02-24 Impact factor: 5.923
Authors: Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Fariba Shojaee-Moradie; Maria Linda Boselli; Geoff Charles-Edwards; Janet Peacock; A Margot Umpleby; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff Journal: BMJ Open Diabetes Res Care Date: 2021-03
Authors: Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Maria Linda Boselli; Fariba Shojaee-Moradie; A Margot Umpleby; Janet Peacock; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff Journal: Acta Diabetol Date: 2021-10-18 Impact factor: 4.280
Authors: Dieter Furthner; Christian-Heinz Anderwald; Peter Bergsten; Anders Forslund; Joel Kullberg; Håkan Ahlström; Hannes Manell; Iris Ciba; Harald Mangge; Katharina Maruszczak; Pia Koren; Sebastian Schütz; Susanne Maria Brunner; Anna Maria Schneider; Daniel Weghuber; Katharina Mörwald Journal: Front Endocrinol (Lausanne) Date: 2022-02-02 Impact factor: 5.555